FTSE Mondo Visione Exchanges Index:

News Centre

News

NZX Operating Metrics February 2007

Date 06/03/2007

Key Facts The NZX 50 Index ended the month on 4,037, a 19% increase since the beginning of 2006. Total number of trades was 50,493, a 15% increase on February 2006. Average number of daily trades was 2,658 for February, a 15% increase on February 2006. Total value traded in February was $2.75 billion, a 1% increase on February 2006. Average daily value traded was $145 million, a 1% increase on February 2006. Total number of tra
CBOE Stock Exchange (CBSX) Launched Today; First Day Volume Was Over 682,000 Shares; Congressman Rahm Emanuel Rang Opening Bell

Date 05/03/2007

The CBOE Stock Exchange, LLC, a subsidiary of the Chicago Board Options Exchange (CBOE), reported that it opened for trading today, with first day volume totaling more than 682,000 shares.
Speech By SEC Chairman: Remarks Before The Women's History Month Program

Date 05/03/2007

Good morning, and welcome to the Securities and Exchange Commission's Women's History Month program. In addition to SEC staff here and in our eleven field offices across the country, I am pleased to welcome some special guests: students from Gonzaga University High School and from Georgetown University Law Center. Thank you for being with us today.
Share Changes In S&P Japan 500 And S&P Japan SmallCap 250 Indices

Date 05/03/2007

Standard & Poor’s will make the following changes in the S&P Japan 500 and S&P Japan SmallCap 250 Indices effective after the close of trading Monday, March 12, 2007: Sankyu Inc (Japan, SEDOL: 6775380, GICS: Industrials, GICS Code: 20304020) a member of the S&P Japan SmallCap250 and S&P Japan 500 indices, shares will increase by 16,000,000 to 305,393,967 due to the public offering
OMX Nordic Exchange Total Derivatives Trading February 2007

Date 05/03/2007

Click here to download the OMX Nordic Exchange's total derivatives trading statistics for February 2007, detailing underlying volumes in derivative trading for Swedish, Finnish, Danish and Norwegian products.

Richard Adamonis, Senior Vice President, Communications, NYSE Group, Inc., On Reg. NMS

Date 05/03/2007

"NYSE Group is, in fact, compliant with Reg. NMS with the exception of the connection to the NASD ADF and the ISE. Currently, we do not believe there is any participation in NYSE-listed stocks in the NASD ADF, and the ISE only launched its stock market this past December. We expect these matters to be completed no later than Apri 5." -- Rich Adamonis, Senior Vice President, Communications, NYSE
Rebalancing Of The S&P/CITIC A Share Indices S&P/CITIC 50, S&P/CITIC 300 Indices & S&P/CITIC Composite

Date 05/03/2007

S&P/CITIC Index Information Services Co., Ltd. will make the following changes to the S&P/CITIC 50, S&P/CITIC 300 and S&P/CITIC Composite Indices as a part the March quarterly rebalancing of index constituent free float shares. The changes listed below will become effective after the close of trading Friday March 16, 2007.
IMF’s Managing Director, Rodrigo de Rato y Figaredo, will open the 3rd International Derivatives and Financial Market Conference

Date 05/03/2007

The International Monetary Fund’s Managing Director, Rodrigo de Rato, will open the 3rd International Derivatives and Financial Market Conference in Campos do Jordão, Brazil, scheduled to be held during the 22nd and 25th of August, 2007. Mr. Rato will speak at the Conference’s official opening ceremony, on Tuesday, and Nobel Prize winner Edmund Phelps will open the plenary sessions on the following day.
Company Share Changes In The S&P/CITIC 300 Index

Date 05/03/2007

S&P/CITIC Index Information Services Co., Ltd. will make the following changes in the S&P/CITIC 300 Index effective after the close of trading on Tuesday March 6, 2007.
Symrise Replaces Schwarz Pharma In MDAX - Deutsche Börse Reviews Index Composition - Changes Are Effective On 19 March

Date 05/03/2007

On Monday, Deutsche Börse has decided on changes in its equity indices MDAX®, SDAX® and TecDAX® that will take effect on 19 March. Symrise will be included in MDAX and will replace Schwarz Pharma. Symrise was admitted on the basis of the so-called fast-entry rule, because the company is ranked 40th or better in terms of both market capitalization and trading volume. Schwarz Pharma will move to SDAX replacing Highlight. In TecDAX BB Medtech will be included replacing the share of Evotec.